Barchart.com
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
7.29 +0.00 (+0.07%) 12:49 ET [NASDAQ]
7.29 x 91 7.31 x 18
Realtime by (Cboe BZX)
7.29 x 91 7.31 x 18
Realtime - - (-) -
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing GlobeNewswire - Mon Apr 21, 3:05PM CDT

MYGN : 7.30 (+0.14%)
Myriad Genetics Announces Inducement Awards GlobeNewswire - Tue Apr 8, 3:15PM CDT

MYGN : 7.30 (+0.14%)
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer GlobeNewswire - Mon Apr 7, 7:00AM CDT

MYGN : 7.30 (+0.14%)
ESAB
1 Small-Cap Stock on Our Watchlist and 2 to Avoid StockStory - Thu Mar 20, 8:01AM CDT

1 Small-Cap Stock on Our Watchlist and 2 to Avoid

MYGN : 7.30 (+0.14%)
ENSG : 125.99 (+1.49%)
ESAB : 118.90 (+3.12%)
VRTX
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack StockStory - Wed Mar 19, 4:05AM CDT

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

MYGN : 7.30 (+0.14%)
VRTX : 491.23 (-0.24%)
BMRN : 62.60 (+1.07%)
GILD : 106.62 (+0.23%)
MRNA : 26.97 (+1.62%)
MYGN
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings? StockStory - Mon Mar 17, 4:10AM CDT

Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?

COST : 971.14 (-0.48%)
MYGN : 7.30 (+0.14%)
MYGN
Why Are Myriad Genetics (MYGN) Shares Soaring Today StockStory - Wed Mar 12, 12:17PM CDT

Why Are Myriad Genetics (MYGN) Shares Soaring Today

MYGN : 7.30 (+0.14%)
Bull and bear at Frankfurt Stock Exchange in Germany_Image by Marco Ritzki via Shutterstock
Nasdaq Climbs as Retaliatory Tariffs Spark Mixed Session on Wall Street Barchart - Wed Mar 12, 10:16AM CDT

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.43%. March E-mini S&P futures (ESH25...

GOOGL : 158.51 (+2.03%)
AMAT : 148.90 (+3.71%)
UAL : 68.98 (+1.40%)
AVGO : 186.93 (+5.66%)
VZ : 43.08 (+0.89%)
CROX : 99.38 (+3.74%)
GRPN : 19.50 (+4.22%)
BF.A : 34.56 (+0.26%)
$IUXX : 19,138.11 (+2.38%)
ZNM25 : 111-060 (+0.48%)
TSLA : 254.90 (+1.66%)
ESM25 : 5,497.75 (+1.78%)
MYGN
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks StockStory - Tue Mar 11, 4:03AM CDT

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
GILD : 106.62 (+0.23%)
ABBV : 180.59 (+2.00%)
MRNA : 26.97 (+1.62%)
SRPT
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4 StockStory - Tue Mar 4, 3:03AM CST

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

SRPT : 61.33 (+3.09%)
MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
ABBV : 180.59 (+2.00%)
MRNA : 26.97 (+1.62%)
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools GlobeNewswire - Thu Feb 27, 3:15PM CST

MYGN : 7.30 (+0.14%)
MYGN
Why Myriad Genetics (MYGN) Shares Are Plunging Today StockStory - Tue Feb 25, 1:07PM CST

Why Myriad Genetics (MYGN) Shares Are Plunging Today

MYGN : 7.30 (+0.14%)
SRPT
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect StockStory - Tue Feb 25, 7:03AM CST

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

SRPT : 61.33 (+3.09%)
MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
UTHR
What To Expect From United Therapeutics’s (UTHR) Q4 Earnings StockStory - Tue Feb 25, 7:03AM CST

What To Expect From United Therapeutics’s (UTHR) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
UTHR : 296.69 (+1.10%)
Myriad: Q4 Earnings Snapshot AP - Mon Feb 24, 4:11PM CST

Myriad: Q4 Earnings Snapshot

MYGN : 7.30 (+0.14%)
MYGN
Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops StockStory - Mon Feb 24, 3:31PM CST

Myriad Genetics (NASDAQ:MYGN) Misses Q4 Sales Targets, Stock Drops

MYGN : 7.30 (+0.14%)
Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth GlobeNewswire - Mon Feb 24, 3:05PM CST

MYGN : 7.30 (+0.14%)
Myriad Genetics Announces Senior Leadership Transition GlobeNewswire - Mon Feb 24, 3:05PM CST

MYGN : 7.30 (+0.14%)
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio GlobeNewswire - Mon Feb 24, 7:30AM CST

MYGN : 7.30 (+0.14%)
MYGN
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings StockStory - Sun Feb 23, 7:01AM CST

What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings

MYGN : 7.30 (+0.14%)
BMRN : 62.60 (+1.07%)
GILD : 106.62 (+0.23%)

Barchart Exclusives

European Commodities: Cocoa Prices Stay Hot Amid Continued Supply Challenges Barchart - 30 minutes ago
Here are the European commodity winners and losers over the past week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot